- Home
- GSL vs INMD Comparison
GSL vs INMD Comparison
Compare GSL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSL
- INMD
- Stock Information
- Founded
- GSL 2007
- INMD 2008
- Country
- GSL Greece
- INMD Israel
- Employees
- GSL N/A
- INMD N/A
- Industry
- GSL Marine Transportation
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GSL Consumer Discretionary
- INMD Health Care
- Exchange
- GSL Nasdaq
- INMD Nasdaq
- Market Cap
- GSL 886.8M
- INMD 887.0M
- IPO Year
- GSL 2006
- INMD 2019
- Fundamental
- Price
- GSL $26.05
- INMD $13.28
- Analyst Decision
- GSL Strong Buy
- INMD Hold
- Analyst Count
- GSL 1
- INMD 6
- Target Price
- GSL $30.00
- INMD $17.56
- AVG Volume (30 Days)
- GSL 370.2K
- INMD 1.1M
- Earning Date
- GSL 08-04-2025
- INMD 07-31-2025
- Dividend Yield
- GSL 8.05%
- INMD N/A
- EPS Growth
- GSL 20.64
- INMD 8.69
- EPS
- GSL 10.54
- INMD 2.29
- Revenue
- GSL $715,232,000.00
- INMD $392,408,000.00
- Revenue This Year
- GSL $3.22
- INMD $0.16
- Revenue Next Year
- GSL N/A
- INMD $4.84
- P/E Ratio
- GSL $2.54
- INMD $5.79
- Revenue Growth
- GSL 3.83
- INMD N/A
- 52 Week Low
- GSL $17.73
- INMD $13.16
- 52 Week High
- GSL $30.19
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- GSL 59.71
- INMD 33.86
- Support Level
- GSL $25.96
- INMD $13.16
- Resistance Level
- GSL $26.66
- INMD $13.67
- Average True Range (ATR)
- GSL 0.57
- INMD 0.40
- MACD
- GSL -0.03
- INMD -0.09
- Stochastic Oscillator
- GSL 65.35
- INMD 7.23
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.